Atlas Trials

A Trial to Assess the Effect of Kidney Impairment on How AMG 133 is Absorbed, Broken Down, and Eliminated by the Body

Clinical trial NCT07429045 · COMPLETED

Trial details

NCT number
NCT07429045
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Overweight and Obesity
Start date
2025-03-11
Primary completion
2025-11-21
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.